Double-Blind, Placebo-Controlled, Active-Referenced, Parallel-Group Comparative Study in Patients With Benign Prostatic Hyperplasia
Latest Information Update: 02 Jan 2019
At a glance
- Drugs AKP 002 (Primary) ; Tamsulosin
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 07 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Jan 2014 New trial record